Randomized results of fixed-duration (1-yr) vs continuous nivolumab in patients (pts) with advanced non-small cell lung cancer (NSCLC)
David Robert Spigel, M. McLeod, Maen Hussein et al. · Annals of Oncology · 2017
Cited by 98 works. doi:10.1093/annonc/mdx380.002 Open-access PDF